Young et al., 1992
The four hero molecules I have endorsed for inclusion in the Syntha-Pep formulation, GHK-Cu, sh-Oligopeptide-1 (the EGF analog), PDRN, and a multi-molecular-weight HA system, are the four with the strongest peer-reviewed clinical evidence supporting their use specifically in a delivery-enhanced context
after treatment it looked plumper and more radiant
TLR4 activation in platelets whether by pathogen- (viremia) or damage-associated molecular patterns induces a prothrombotic and proinflammatory state (Schattner, 2019)
GHK-Cu Titration Protocols: A Biomarker-Informed Framework Titration strategies for GHK-Cu are individualized, typically starting at lower doses and increasing over 412 weeks based on clinical response, injection site tolerance, and biomarker trends
Mistakes here compound throughout the entire vial